Cardiovascular

Latest News

Breast cancer awareness graphic | image credit: ST.art - stock.adobe.com
Breast Cancer Stage May Influence Risk of Prevalent CVD

January 15th 2025

Patient outcomes appeared to be more heavily driven by breast cancer stage than delays in diagnosis, researchers found.

heart of pills-Denira-stock.adobe.com
Economic Data Show Cost-Effectiveness of Statin, Antihypertensive Polypill for CVD in Low-Income Populations

January 14th 2025

Coffee | Image credit: dimakp - stock.adobe.com
Lower Risk of Cardiovascular Disease Mortality Associated With Morning Coffee

January 9th 2025

Cardiovascular top 5 of 2024 | Image Credit: Venngage
Top 5 Most-Read Cardiovascular Content of 2024

December 25th 2024

AHA 2024 Highlights
ICYMI: AHA 2024 Scientific Session Highlights

December 20th 2024

Advancements in Population Health Strategies for Cardiovascular Risk Management

Experts discuss how lipoproteins drive atherosclerotic heart disease, review the different guidelines and recommendations on Lp(a) testing, and insights from clinical trials.

Hands holding a heart with a heartbeat on it and the words AJMC Insights
Continuing Medical Education
View All
January 18th 2025

Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment

1.5 Credits / Cardiology, Neurology, Rare Diseases
January 18th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
January 18th 2025

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

1.0 Credit / Cardiology

More News

Dr Javed Butler Notes Subgroup Efficacy Differences of Vericiguat in VICTORIA Trial Findings
March 29th 2020

Dr Javed Butler Notes Subgroup Efficacy Differences of Vericiguat in VICTORIA Trial Findings

In VICTORIA, patients within the first 3 quartiles of peptide elevation had results more impressive than the overall findings. However, patients with the highest quartile did not seem to benefit. This raises the question whether the sickest of the sick patients will benefit from vericiguat, said Javed Butler, MD, MPH, MBA, chairman for the Department of Medicine at the University of Mississippi.
Dr Richard Kovacs on How ACC Is Leading the Charge for Credible Clinical Data Amid COVID-19
March 28th 2020

Dr Richard Kovacs on How ACC Is Leading the Charge for Credible Clinical Data Amid COVID-19

We need more than ever credible clinical data both on the pandemic, but also how to understand how the pandemic’s going to affect patients in the cardiovascular field, said Richard Kovacs, MD, FACC, clinical cardiologist and president of the American College of Cardiology (ACC).
Dr Javed Butler on Key Takeaways of Vericiguat Found in VICTORIA Trial Participants With HFrEF
March 28th 2020

Dr Javed Butler on Key Takeaways of Vericiguat Found in VICTORIA Trial Participants With HFrEF

Results from VICTORIA show vericiguat produced a 10% relative risk reduction in the highest-risk patients with heart failure. Study patients had about 3 times the health risk seen in recent heart failure trials, which showed higher relative risk reductions. However, VICTORIA saw a 4% absolute risk reduction, which is the same as the others, said Javed Butler, MD, MPH, MBA, chairman for the Department of Medicine at the University of Mississippi.
What We're Reading: Probing Age Bias in Heart Care; Coronavirus Ship Deaths; Housing and Health
February 20th 2020

What We're Reading: Probing Age Bias in Heart Care; Coronavirus Ship Deaths; Housing and Health

AJMC Staff
A study found potential age bias in heart care for patients on different sides of their 80th birthday; 2 passengers from the Diamond Princess cruise ship die of coronavirus; California Governor Gavin Newsom outlined several mental health proposals to address homelessness in the state.
6 Connected Patient Challenge Finalists to Compete in Live Pitch-Off
February 18th 2020

6 Connected Patient Challenge Finalists to Compete in Live Pitch-Off

Samara Rosenfeld
The 6 finalists will pitch their innovations at Google’s campus February 27 for a chance to win up to $50,000 in in-kind services from Boston Scientific and Google.
PAPER OF THE WEEK: The Links Between Metabolic Syndrome and Mental Illness
February 16th 2020

PAPER OF THE WEEK: The Links Between Metabolic Syndrome and Mental Illness

Mary Caffrey
The 2007 paper examined the elevated risks for cardiovascular disease and type 2 diabetes for patients who have schizophrenia or bipolar disorder.
What We're Reading: Cancer Clinical Trials; Affordable Housing From CVS; Drug Developed via Artificial Intelligence
February 12th 2020

What We're Reading: Cancer Clinical Trials; Affordable Housing From CVS; Drug Developed via Artificial Intelligence

AJMC Staff
Cancer drug trials often do not report on cardiovascular outcomes; CVS is investing in affordable housing to reduce overall healthcare costs; a drug for obsessive compulsive disorder that was developed through artificial intelligence will soon be tested in humans.
Site Logo
February 10th 2020

Economic Value of Transcatheter Valve Replacement for Inoperable Aortic Stenosis

Jesse Sussell, PhD Emma van Eijndhoven, MS, MA Taylor T. Schwartz, MPH Suzanne J. Baron, MD, MSc Christin Thompson, PhD Seth Clancy, MPH Anupam B. Jena, MD, PhD
Transcatheter aortic valve replacement for inoperable severe, symptomatic aortic stenosis will create significant social value in the next decade, mostly accruing to patients versus manufacturers.
Semaglutide Approved for Cardiovascular Risk Reduction in Adults With T2D
January 17th 2020

Semaglutide Approved for Cardiovascular Risk Reduction in Adults With T2D

Gianna Melillo
Novo Nordisk announced Thursday the FDA has approved injectable semaglutide (Ozempic) for adult patients with type 2 diabetes (T2D) and known heart disease.
Understanding Diabetes Risks Can Save Your Limbs
December 4th 2019

Understanding Diabetes Risks Can Save Your Limbs

Gerald Niedzwiecki, MD
Dr John McMurray Explains the Heart Failure Benefits of Dapagliflozin in Patients With and Without Diabetes
November 23rd 2019

Dr John McMurray Explains the Heart Failure Benefits of Dapagliflozin in Patients With and Without Diabetes

In patients with heart failure, both with and without diabetes, dapagliflozin was shown to provide identical efficacy and possibly beneficial effects on the heart, said John McMurray, MD, FRCP, FESC, professor of medical cardiology in the Institute of Cardiovascular and Medical Sciences at the University of Glasgow.
Migraine Attack in Response to Nitroglycerin Showed Greater Cardiovascular Responses, Study Finds
November 16th 2019

Migraine Attack in Response to Nitroglycerin Showed Greater Cardiovascular Responses, Study Finds

Alison Rodriguez
A study investigating the cardiovascular responses to nitroglycerin in migraine found that migraineurs who developed a migraine-like attack in response to nitroglycerin demonstrated greater systemic cardiovascular responses compared with non-headache controls.
What We're Reading: Google, Ascension Plan Draws Scrutiny; Vascepa Goes Before FDA; Verma Defends Medicaid Changes
November 13th 2019

What We're Reading: Google, Ascension Plan Draws Scrutiny; Vascepa Goes Before FDA; Verma Defends Medicaid Changes

AJMC Staff
Regulators and lawmakers have expressed concern over possible privacy breaches as Google and Ascension collect healthcare data; Amarin’s Vascepa goes before an FDA committee this week; CMS Administrator Seema Verma defends Medicaid work requirements.
What We're Reading: Gilead Sued Over PrEP; Seasonal Workers and Medicaid; Preventable Deaths
November 8th 2019

What We're Reading: Gilead Sued Over PrEP; Seasonal Workers and Medicaid; Preventable Deaths

AJMC Staff
HHS takes action against Gilead; a report on fears of seasonal workers in Montana; the latest CDC data on preventable deaths show differences between urban and rural areas.
Dr Danielle Kirkman Explains How Exercise Testing in Patients With CKD Can Improve Care
November 8th 2019

Dr Danielle Kirkman Explains How Exercise Testing in Patients With CKD Can Improve Care

Because exercise capacity is known to be linked with several key outcome measures in patients with chronic kidney disease (CKD), routine exercise testing can help clinicians prescribe individualized exercise interventions, said Danielle Kirkman, PhD, assistant professor at Virginia Commonwealth University.
Cleveland Clinic Announces Top 10 Medical Innovations for 2020
October 25th 2019

Cleveland Clinic Announces Top 10 Medical Innovations for 2020

Matthew Gavidia
Cleveland Clinic announced the top 10 medical innovations for 2020, which details the medical advancements that have the potential power in transforming healthcare in the next year, at a multimedia presentation during the 2019 Medical Innovation Summit.
Study Examines Cardiovascular Disease Impact in Patients With COPD
September 28th 2019

Study Examines Cardiovascular Disease Impact in Patients With COPD

Alison Rodriguez
A recent study investigating the cardiovascular contribution to COPD symptoms and their relationship to a patient's diagnostic status found that patients with suspicious echocardiographic findings were undiagnosed and untreated.
USDA's Topics for the 2020 Dietary Guidelines Committee Exclude Underlying Catalysts for Lifestyle Disease
September 11th 2019

USDA's Topics for the 2020 Dietary Guidelines Committee Exclude Underlying Catalysts for Lifestyle Disease

Matthew Gavidia
Predetermined topics to be discussed by the 2020 dietary guidelines committee failed to mention risks correlated to red meat, processed foods, and appropriate sodium intake, which contribute to the impending epidemic of lifestyle diseases.
People Who Sleep Too Much, or Too Little, at Heightened Risk of Heart Attack
September 5th 2019

People Who Sleep Too Much, or Too Little, at Heightened Risk of Heart Attack

Matthew Gavidia
Less than 6 hours of sleep, as well as durations of longer than 9 hours, are associated with a greater risk of heart attack, according to a new study.
Men With Lower Cardiovascular Fitness at Higher Risk for Migraine, Swedish Study Says
September 4th 2019

Men With Lower Cardiovascular Fitness at Higher Risk for Migraine, Swedish Study Says

Allison Inserro
Young men with a lower level of cardiovascular fitness had a higher risk of developing migraines, according to a recent national, population-based cohort study from Sweden.
Site Logo
September 4th 2019

New Guidelines Supported by Lipid-Lowering Therapy Studies, Indicating Benefit of PCSK9 Inhibitors

Matthew Gavidia
Studies on PCSK9 inhibitors, evolocumab and alirocumab, promote new guidelines for dyslipidemia management through lipid modification to reduce cardiovascular risk.
Dapagliflozin Cuts Risk of CV Death, Worsening of Heart Failure 26%, Whether Diabetes Present or Not
September 1st 2019

Dapagliflozin Cuts Risk of CV Death, Worsening of Heart Failure 26%, Whether Diabetes Present or Not

Mary Caffrey
Dapagliflozin, sold by AstraZeneca as Farxiga, cut the risk of cardiovascular (CV) death and worsening of heart failure (HF) by 26% among patients with reduced ejection fraction alongside standard of care, according to results of a landmark phase 3 study presented Sunday at the European Society of Cardiology 2019 Congress. Results confirmed that the sodium glucose co-transporter 2 (SGLT2) inhibitor, already approved to treat type 2 diabetes (T2D), is just as effective in preventing CV death and HF events in patients who do not have T2D.
Apixaban Shows Lower Rate of Bleeding in Large French Real-World Data Study
September 1st 2019

Apixaban Shows Lower Rate of Bleeding in Large French Real-World Data Study

Mary Caffrey
Data in the real-world study included a large share of patients over the age of 80, who are representative of those doctors see in clinical practice.
FDA Grants Fast Track Designation for Dapagliflozin to Prevent Kidney Failure
August 27th 2019

FDA Grants Fast Track Designation for Dapagliflozin to Prevent Kidney Failure

Matthew Gavidia
Dapagliflozin’s fast track designation follows findings from last year’s DECLARE-TIMI trial, a cardiovascular outcomes trial that showed the drug’s significant impact on delaying the loss of kidney function and reducing hospitalization risk for heart failure.
5 Things to Look for at the European Society of Cardiology 2019 Congress
August 23rd 2019

5 Things to Look for at the European Society of Cardiology 2019 Congress

Mary Caffrey
Studies on anticoagulants and SGLT2 inhibitors, and guidelines for dyslipidemia and more are anticipated at the meeting.
Air Pollution Found to Be Possible Cause of Premature Death Rates
August 22nd 2019

Air Pollution Found to Be Possible Cause of Premature Death Rates

Matthew Gavidia
Researchers found evidence correlating toxic air pollutants to increased respiratory and cardiovascular death rates.
Site Logo
August 19th 2019

Prescription Omega-3 Fatty Acids Effectively Reduce Triglycerides, AHA Says in Advisory

Mary Caffrey
Interest in omega-3 fatty acids have increased since publication of the results of REDUCE-IT.
Improving Heart Health at Age 50 Can Reduce Dementia Risk Later in Life
August 9th 2019

Improving Heart Health at Age 50 Can Reduce Dementia Risk Later in Life

Laura Joszt, MA
People who have better cardiovascular health, as scored by the American Heart Association's Life's Simple 7, at age 50 have a lower risk of developing dementia over the next 25 years, according to a new study.
Rejected, Unfilled PCSK9 Inhibitor Prescriptions Linked to Higher Risk of Cardiovascular Events
July 23rd 2019

Rejected, Unfilled PCSK9 Inhibitor Prescriptions Linked to Higher Risk of Cardiovascular Events

Jaime Rosenberg
Patients were 16% more likely to have a cardiovascular event if their prescription was rejected and 21% more likely to have a cardiovascular event if they did not fill their prescription.
HHS Unveils 5 New Payment Models to Transform Kidney Disease Care
July 10th 2019

HHS Unveils 5 New Payment Models to Transform Kidney Disease Care

Jaime Rosenberg
Following an executive order from President Donald Trump, HHS announced the launch of Advancing American Kidney Health, an initiative to improve the health of the 37 million Americans living with kidney disease, by releasing 5 new payment models.
<1
...
34567891011
...
22>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo